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ORIGINAL ARTICLE
Impressive evidence exists to support the value of
using screening tools to promote health and to
reduce risk factors that result in diseases and injury.
Although preventive services have decreased mor-
bidity and mortality in a variety of conditions,
the services are generally underutilized. Possible
barriers result from physicians, patients, and health
systems that fail to provide adequate reimburse-
ment, sharable information, and specific preven-
tive services.1 Strategies to improve the delivery of
preventive services include the establishment of
practice guidelines, incorporation of computerized
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reminder systems into primary care, enhancement
of education to health providers, and modifica-
tion of patient behavior.2
The recent acceptance of an evidence-based
approach to preventive management has facili-
tated the development of clinical guidelines and
recommendations. The US Preventive Services
Task Force (USPSTF), an independent panel of
experts in primary care and prevention, systemat-
ically reviewed the evidence of effectiveness and
developed recommendations for clinical pre-
ventive services.3 Through the evidence-based
approach, recommendations for preventive prac-
tices can be categorized into different ranks.
USPSTF grades its recommendations into five
classifications (A, B, C, D, I) reflecting the strength
of evidence and magnitude of net benefit.4 With
recommendations A and B, the preventive ser-
vice is “strongly recommended” and “recom-
mended” to eligible subjects when the benefits
“substantially outweigh” or “outweigh” harms,
respectively.4
Computerized decision support systems
(CDSS) provide clinicians with patient-specific
assessments or recommendations to aid clinical
decision making.5 Tierney et al designed computer-
generated reminders for 13 preventive care pro-
tocols at the time of patient encounter and
found that clinicians’ compliance was increased
in only three out of 13 protocols.6 In addition to
reminding physicians, mailing reminders to pa-
tients might result in higher overall compliance
with preventive care guidelines.7–9 Kawamoto et al
demonstrated that a significant improvement in
clinical practice could be found in 30 out of 32
CDSS that contained all the following special
features: (1) automatic provision of decision as
part of clinical workflow; (2) provision of rec-
ommendations rather than just assessments; (3)
provision of decision support at the time and lo-
cation of decision making; and (4) computer-
based decision support.10
The purpose of this study was to implement a
computer-based guideline-driven multiple screen-
ing program in an outpatient setting as well as to
evaluate its impacts on facilitating preventive
care in terms of expected life saving and cost-
effectiveness.
A protocol was designed and applied in Yun-Lin,
Taiwan, an agricultural county where medical serv-
ices are deficient and the concept of disease pre-
vention is not widely accepted.11 The program
provided physicians with preventive service re-
minders and gave patients health care education,
direct access to health consultation, and preventive
tools so that all the required features of CDSS
mentioned above were complied with. Multiple
diseases were screened simultaneously if eligibility
was met so as to fulfill the USPSTF recommenda-
tions. The program was evaluated to determine if
there was increased patient attendance to preven-
tive services, and an overall cost-effectiveness.
Patients and Methods
Subjects
National Taiwan University Hospital Yun-Lin
Branch (NTUH-YL) is the only quasi-medical cen-
ter in Yun-Lin, Taiwan, an agricultural county with
a population of 700,000, since April 2004. The
number of new registrations to its outpatient de-
partment (OPD) is about 3000 per month. Under
the current national insurance policy in Taiwan,
referral is not mandatory for patients from gen-
eral medicine/family medicine service to other
specialties. Since the preventive service program
was designed to facilitate preventive interventions
at the frontline clinical encounter, patients who
first attended any clinic in NTUH-YL in June and
July 2005 were recruited into the multiple screen-
ing program.
Selection of screening tools
The clinical preventive services recommended by
USPSTF ranked in A and B were incorporated into
the screening program. Screening tools involving
pediatric conditions, obstetric and gynecologic
conditions, and sexually transmitted diseases were
excluded. A total of 11 preventive services were in-
cluded: (1) aspirin chemoprevention for coronary
heart diseases (CHD);12 (2) screening for type 2
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diabetes in adults with hypertension or hyperlipi-
demia;13,14 (3) screening for lipid disorders;15 (4)
screening for high blood pressure;16 (5) screening
for obesity;17 (6) screening for tobacco use;18 (7)
screening for depression;19 (8) screening for colo-
rectal cancer;20 (9) screening for breast cancer;21
(10) screening for cervical cancer;22 and (11) screen-
ing women aged ≥ 65 years for osteoporosis.23,24
Each male subject was screened with the first
eight preventive tools and each female with all 
of 11 if eligibility was met. Clinical inclusion/
exclusion criteria and the preventive interven-
tions are shown in Table 1. A male subject had to
be aged ≥ 35 years so as to be eligible for screen-
ing for lipid disorder. A sexually active woman
≥ 21 years old needs to have regular Pap smear
examinations. In order to recruit high-risk subjects,
the age-specific criterion was set at 35 for men and
21 for women.
Questionnaire design
An initial survey was performed by mailing a
questionnaire to patients who had just visited
NTUH-YL in the 2-month period. The items in the
questionnaire were designed to collect clinical
information sufficient to trigger all the eligibility
rules for the 11 preventive services. The major sec-
tions included: (1) demographic data (name, sex,
age, marriage status); (2) basic measurements
(body height and weight, systolic and diastolic
blood pressure, hip and waist circumferences);
(3) past history of smoking, hypertension, dia-
betes mellitus, dyslipidemia, peptic ulcer disease
and upper gastrointestinal bleeding, intracranial
hemorrhage, colon cancer, and aspirin use; (4)
previous examinations (e.g. stool occult blood
test); (5) Taiwanese Depression Score (a total of
18 items with questions related to sleep pattern,
mood, and psychosomatic symptoms);25 (6)
women-specific items (e.g. history of menstrua-
tion, childbirth, breastfeeding, hormone replace-
ment therapy, breast and cervical cancer, past
examination of Pap smear and mammography,
family history of breast cancer); and (7) informed
consents agreeing to accept mammography, Pap
smear, and bone mineral density test.26
Table 1. Selection of preventive services, and inclusion and exclusion criteria
Preventive services (abbreviation) Inclusion criteria Exclusion criteria
1. Aspirin chemoprevention (AS) All adults Current use of aspirin
2. Screening for type 2 diabetes (DM) a. Adults with hypertension Known diabetes
b. Adults with dyslipidemia
c. Adults with obesity
3. Screening for lipid disorder (LD) a. Men aged ≥ 35 yr Known dyslipidemia
b. Women aged ≥ 45 yr
c. High coronary risk
4. Screening for hypertension (HTN) All adults Known hypertension
5. Screening for obesity (OBE) All adults
6. Tobacco use and cessation (TO) All adults
7. Screening for depression (DE) All adults
8. Screening for colorectal cancer (CO) Men and women aged ≥ 50 yr a. Past history of colorectal cancer
b. Previous stool occult blood in last 1 year
9. Screening for breast cancer (BC) Women aged ≥ 40 yr a. Past history of breast cancer
b. Previous mammography in last 2 years
10. Screening for cervical cancer (CC) Sexually active women with intact cervix a. Past history of cervical cancer
aged ≥ 21 yr b. Previous hysterectomy
c. Previous Pap smear in last 1 year
11. Screening for osteoporosis (OS) Women aged ≥ 65 yr
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The questionnaire designed for men and
women contained a total of 45 and 63 items, respec-
tively. A prepaid stamp was attached for the inter-
viewees to conveniently return the questionnaire.
Building a computerized decision 
support system
A user interface was designed under the VISUAL
BASIC (VB) environment. The input was linked
into a Microsoft Access database for data storage
and production rule operation. Clinical risk calcu-
lators were embedded. A modified Framingham
coronary risk was estimated with information
about sex, age, smoking, blood pressure (BP), and
antihypertensive medication; subjects were cate-
gorized into 10-year coronary risk < 10%, 10–20%,
and > 20% when serum levels of total cholesterol
and high-density lipoprotein were not available
at the time of mail interview.27 The Taiwanese
Depression Score that contained 18 items of 
answers from 0 to 3 (a total score ranging from 
0 to 54) detects high-risk patients for depression
when the score is > 29.25 Women-specific data
were imported to the Osteoporosis Risk Assess-
ment Instrument (ORAI)28 and Taiwanese Breast
Cancer Score (TBCS) Calculator.29 When ORAI is
> 9 in women aged ≥ 65 years, they were regarded
as being at high risk for osteoporosis; when
TBCS is > 0 in women aged 50 years, they were
eligible for free mammographic screening under
the current policy of Taiwan. Production rules were
coded in VB to execute simple Boolean operations
to deduce eligibility for each of the 11 preventive
services (Tables 1 and 2).
Table 2. Workflow in patient education, preventive intervention, and physician reminders in each preventive service
Preventive
Patient education Action Instruction to physician
services
AS Explain high coronary risk and Appoint a cardiovascular clinic Prescribe aspirin if indicated
possible consequences if 10-yr coronary risk > 10%*
DM Explain why diabetes screening Appoint a primary care clinic Arrange blood test for fasting
is necessary glucose & OGTT
LD Explain why lipid screening Appoint a primary care clinic Arrange blood test for fasting TG,
is necessary TC & HDL-C
HTN a. Explain why hypertension a. Arrange daily BP measurement Ask physician to confirm diagnosis of
screening is necessary for 1 wk hypertension and take appropriate steps
b. Educate patient to measure BP b. Appoint a primary care clinic 
1 wk later
OBE Explain consequences of obesity Activate DM, LD & HTN screening Give diet and exercise education
TO Explain risks of smoking Appoint a stop-smoking clinic Ask physician to consult patient on
smoking abstinence and consider 
nicotine replacement
DE Explain risks for depression Appoint a psychiatric clinic Ask psychiatrist to give depression
if TDS† > 29 evaluation and appropriate treatment
CO Explain risks of colorectal cancer Appoint a primary care clinic Ask physician to perform stool OB
test and check results
BC Explain risks of breast cancer Arrange mammography in (High-risk women went for 
women with TBCS‡ > 0 mammography directly. Reports were
mailed to patients.)
CC Explain risks of cervical cancer Appoint a gynecologic clinic Ask gynecologist to perform Pap smear
OS Explain risks of osteoporosis Arrange BMD in women Ask physician to arrange BMD
with ORAI§ > 9
*Modified Framingham Coronary Risk Score (Reference 27); †TDS = Taiwanese Depression Score (Reference 25); ‡TBCS = Taiwanese Breast Cancer Score
(Reference 29); §ORAI = Osteoporosis Risk Assessment Instrument (Reference 28). OGTT = oral glucose tolerance test; TG = triglycerides; TC = total cholesterol;
HDL-C = high-density lipoprotein cholesterol; BP = blood pressure; OB = occult blood; BMD = bone mineral densitometry.
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Preventive interventions
Once the questionnaire was filled and returned
by mail, the data were manually coded through
the computer interface. The actions shown in
Table 2 contained components in patient educa-
tion, clinic scheduling, arrangement in preven-
tive intervention, and physician reminding. A note
recording the time, date, and specialty of the next
clinic visit as well as education materials was
sent to the patient in the second mail. Physicians
participating in this study were previously in-
structed to take appropriate steps and were
prompted with clinical reminders as the patient
presented to the clinic.
Patients who responded to the mailed instruc-
tions and returned to the primary care clinic as
appointed were arranged to receive preventive
services: blood tests for fasting glucose and oral
glucose tolerance test (DM), lipid profile (LD),
stool occult blood (CO), and bone mineral densit-
ometry (OS) as indicated. A complete evaluation
of cardiovascular risk and physical examination
were performed; aspirin was prescribed under a
cardiologist’s discretion (AS). Serial BP measure-
ments were arranged if initial screening showed
BP > 140/90 mmHg (HTN). High-risk patients
for cervical cancer, depression, and those who
agreed to stop smoking were appointed to the 
gynecologic clinic for Pap smear (CC), psychiatric
clinic for consultation (DE), and smoking absti-
nence clinic (TO), respectively. Mammographic
examination was directly scheduled without inter-
vention of physicians (BC) (Table 2).
Follow-up clinics were arranged and continu-
ing care was provided to ensure BP monitoring,
check test results, prescribe antihypertensive, oral




A returned questionnaire was regarded as valid if
all of the production rules of the 11 preventive
services could be checked. The total number of
blank questionnaires that were sent to the subjects
minus the number of undelivered mails (due to
incorrect addresses, etc.) was used as the denomi-
nator. The questionnaire response rate was defined
as the ratio between the two.
Attendance rate
An overall attendance rate to the multiple screen-
ing program was calculated for men and women
separately. If a subject received any one of the
suggested screening services in addition to obesity
measurement at the initial survey, his/her atten-
dance was approved. Attendance rate according to
each of the preventive services, defined as dividing
the number of patients actually taking a screening
examination by the number of patients assigned
as high risk, was also calculated and stratified 
by sex.
Effectiveness
Data concerning “the number needed to screen
to save a life (NNS)” of each preventive service
was derived from USPSTF-cited references.3 If such
information was not available from the official
website, Medline and PubMed were searched to
find the best evidence that represented the most
identical screening strategy and risk groups. The
expected effectiveness of any of the 11 preventive
tools was the number actually screened divided by
NNS. It represented the expected life that would
have been saved due to a specific tool. The overall
effectiveness of the screening program was the sum
of the 11 components.
The total effectiveness of the multiple screening
program could also be represented by: (1) the
number needed to attend the program to save 
a life; and (2) the number of questionnaires
needed to send to save a life. The former is de-
fined as the ratio between the number of cases
requiring an attendance for preventive services to
the overall expected life saved by the 11 preven-
tive tools. The latter is defined as the ratio be-
tween the number of questionnaires sent out for
mail interview to the overall expected life saved
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Cost-effectiveness analysis (CEA)
Calculated cost-effectiveness ratio (Calculated
C/E) is defined as the sum of the C/E of the 11
preventive tools weighed by the expected life
saved attributed to each service. Since there were
almost no local data in Taiwan concerning C/E
in terms of dollars per life-year saved (USD/LYS),
information about economic impacts was also
obtained from existing evidence. The C/E reported
in different monetary units were exchanged to US
dollars (USD, $). C/E that was previously reported
in dollars per quality-adjusted life-year (QALY)
was arbitrarily expanded to dollars per life-year
saved (LYS) (e.g. $15,000/QALY $15,000/LYS)
so that all of the C/E might be weighed and
summed up. Additional costs, either direct or 
indirect, accrued by development of the com-
puter system, management of the screening 
program, physicians’ intervention, and patient
visit, were subsequently added, after normaliza-
tion to 1 LYS, to measure the C/E of the overall
program.
Statistical analysis
Data in the Microsoft Access database were 
exported into SPSS version 11 (SPSS Inc., Chicago,
IL, USA) for analysis. The attendance rates of men
and women were compared using the χ2 test.
Fisher’s exact test was used instead if the case
number was small.
Results
A total of 5600 questionnaires were mailed to the
patients who newly visited NTUH-YL in June and
July 2005. Of those, 185 were not delivered due to
incorrect addresses. Returned questionnaires were
identified as valid in 314 men and 223 women.
The questionnaire response rate was 9.6%.
The mean age for those who returned their
questionnaires were 55 ± 15 years for men and
50 ± 14 years for women. The prevalence of
known diabetes, dyslipidemia, and hypertension
in this selected group are shown in Table 3.
Aspirin had been used in 9.6% of men and 8.5%
of women. The prevalence of obesity, defined in
Taiwan as body mass index (BMI) > 27 kg/m2 or
waist circumference > 90 cm in men or > 80 cm
in women,30 was 44% in both sexes. Tobacco use
was highly prevalent in men, but was only a rare
habit in the women of Yun-Lin. In addition,
some patients already had depression, colorectal
cancer, breast cancer, and cervical cancer before
the survey had been initiated (Table 3).
The CDSS evaluated eligibility and showed
that 283 of 314 men (90.1%) and 199 of 223
women (89.2%) needed at least one preventive
intervention. The percentage of male subjects who
required one to at most six preventive interven-
tions was 12.4%, 17.2%, 22.0%, 28.0%, 9.2% and
1.3%, respectively. Female subjects also required
Table 3. Prevalence in patients who replied to the questionnaires
Preventive services
Men (n = 314) Women (n = 223)
Case number Prevalence (%) Case number Prevalence (%)
AS (current aspirin use) 30 9.6 19 8.5
DM 42 13.4 13 5.8
LD 89 28.3 44 19.7
HTN 100 31.8 62 27.8
TO (current smoking) 113 36.0 6 2.7
DE 2 0.6 1 0.4
CO 2 0.6 3 1.3
BC N/A N/A 2 0.9
CC N/A N/A 7 3.1
OS N/A N/A 0 0.0*
*Osteoporosis was not known to any of the women who replied to the questionnaire. N/A = not available.
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one to six interventions; the percentages were
15.7%, 9.9%, 21.5%, 20.6%, 15.7% and 5.8%,
respectively.
The overall attendance rate, the proportion of
people who took at least one preventive inter-
vention, was 62.2% and 52.3% for men and
women, respectively (p = 0.031). The attendance
rates for each specific preventive service are
shown in Table 4. It was found that 120 men and
15 women had an estimated 10-year coronary risk
> 10%. After clinical evaluation at the cardiology
clinic, aspirin was newly prescribed to 22 men
(18.3%) and two women (13.3%). Since BMI,
waist and hip circumferences were required items
in the initial survey, the screening rate for obesity
was 100% for valid cases. Screening for diabetes,
hypertension and dyslipidemia was achieved in
35% to 56%. Stool occult blood test was per-
formed in 41.5% of men and 23.0% of women.
With regard to specific preventive services, men
demonstrated a higher attendance than women,
but statistical significance was reached only in dia-
betes and colorectal cancer screening (Table 4).
The yield rate of diabetes mellitus was 13.4%
for men and 9.8% for women in the high-risk
group. Hypertension was confirmed in five of 
60 men (8.3%) and two of 29 women (6.9%)
who actually underwent serial BP measurements.
Dyslipidemia (definition in Table 4) was found
in 53 of 77 men (68.8%) and 16 of 42 women
(38.1%). Positive stool occult blood was detected
in two of 68 men (2.9%) and one of 23 women
(4.3%). Colofibroscopic examinations showed
internal hemorrhoid and tubular adenoma in
the two men; the women refused colofibroscopy.
Those who did visit the psychiatric clinic (n = 3)
were all diagnosed as having depression and re-
ceived consultation and antidepression medica-
tion. The cytology of those who took Pap smear
(n = 6) was all within normal limits. Benign breast
lesions but no malignancy were found in six of
seven women who received mammography. Only
three aged women had bone mineral densitome-
try test and all of them were diagnosed with osteo-
porosis and started treatment (Table 4).
The total effectiveness of the overall program in
terms of “expected life saved” ranged from 0.475
to 1.169 (Table 5),31–39 which corresponds to the
number needed to attend the program to save a
life of 412 to 1014. A total of 5600 questionnaires
were sent and 482 subjects required an attendance
for preventive services; the number of question-
naires needed to send to save a life would be
around 4787–11,780.
Table 4. Eligible case number, attended case number (attendance rate), and yield (yield rate) of each preventive service in
men and women
Preventive Men Women Difference in attendance
services Eligible cases Attendance Yield Eligible cases Attendance Yield p
AS 120 22 (18.3%) N/A 15 2 (13.3%) N/A N/S
DM 186 97 (52.2%) 13 (13.4%) 119 41 (34.5%) 4 (9.8%) 0.003
LD* 192 77 (40.1%) 53 (68.8%) 118 42 (35.6%) 16 (38.1%) 0.471
HTN 107 60 (56.1%) 5 (8.3%) 62 29 (46.8%) 2 (6.9%) 0.266
OBE 139 N/A N/A 99 N/A N/A N/A
TO 113 12 (10.6%) N/A 6 0 (0.0%) N/A N/S
DE 10 3 (30.0%) 3 (100%) 7 0 (0.0%) N/A 0.228
CO 164 68 (41.5%) 2 (2.9%) 100 23 (23.0%) 1 (4.3%) 0.002
BC N/A N/A N/A 52 7 (13.5%) 0 (0.0%)† N/A
CC N/A N/A N/A 60 6 (10.0%) 0 (0.0%) N/A
OS N/A N/A N/A 17 3 (17.6%) 3 (100%) N/A
*Dyslipidemia defined as high-density lipoprotein cholesterol < 40 mg/dL or triglycerides > 200 mg/dL or low-density lipoprotein cholesterol > 160 mg/dL,
130 mg/dL or 100 mg/dL in subjects whose 10-year coronary risk < 10%, 10–20%, or > 20%, respectively; †benign lesions but no malignancy found in six
out of seven women. N/A = not available; N/S = non-significant.
Guideline-driven screening program in Yun-Lin
J Formos Med Assoc | 2007 • Vol 106 • No 1 65
The calculated C/E of combining the 11 pre-
ventive tools was estimated to range between
$21,997/LYS and $32,587/LYS (Table 5).40–51 It
represented the weighed average of C/E attributed
to lipid screening (34.6%), hypertension screen-
ing (23.9%), diabetes screening (19.1%), and col-
orectal cancer screening (13.1%), and the others.
Extra costs, which were not counted and should
be added, included: (1) the development and
maintenance of the CDSS ($6000); (2) spending
on questionnaires, mails, educational materials,
and appointments to the clinics ($927); (3) doc-
tor fee ($4200); and (4) indirect cost of patients
who lost their productivity due to the extra visit
to the clinic ($8400). All of these additional
costs added up to $19,527, with an average of
0.822 life saved in the overall program, corre-
sponding to an increased cost of $23,755 for
each life saved.
Discussion
The CDSS-embedded screening program in NTUH-
YL, which presented all the special features needed
for CDSS to achieve successful improvement in
clinical practice,10 was able to facilitate the atten-
dance rate to preventive services and result in 
expected life saving.
The multiple screening program was economic.
By weighing the contribution of the 11 preventive
tools, the calculated C/E of the overall program
was estimated to range between $21,996/LYS and
$32,587/LYS. Extra costs resulting from the imple-
mentation of the screening program was estimated
as $23,755 for each life saved. Assuming that “each
life saved” would result in 3–5 “life-years saved”,
the C/E would be increased by $4751/LYS to
$7918/LYS. Therefore, the final estimate of the C/E
of the overall program would be in the range of
$26,747/LYS to $40,505/LYS. Traditionally, an
intervention that results in a C/E < $50,000/LYS
is regarded as being highly cost-effective. The
overall cost-effectiveness of the computer-aided
screening program compared to no screening fell
in a very favorable range.
Due to the low response rate to the initial mail
survey, phone interviews were given to a propor-
tion of people who did not reply. Major reasons
of these nonresponders included the lack of time
or motivation to answer a questionnaire. Most of
the phone interviewees agreed that the explanation




Range Cost-effectiveness ratio Expected life saved
Calculated C/E
services to screen (US$/LYS)
AS31,40 24 to save a life 370–2500 5318–11,203 Euro/LYS 0.037 (0.010–0.065) 296–624
DM32,41 138 to save a life 500–3600 US$34,375/QALY 0.157 (0.038–0.276) 6568
LD33,42,43 119 to save a life 418 US$28,000–48,000/LYS 0.284 9692–16,615
HTN33,44,45 89 to save a life 274 US$15,000–23,000/QALY 0.196 (0.068–0.325) 3583–5493
OBE N/A (trigger DM, LD, N/A N/A
HTN screening)
TO34,46 12 to stop 1 smoking 9–26 US$300–790 pound/QALY
DE35,47 3 to get a remission 17 US$32,503–50,988/QALY
CO33,48 91 to save a life 562–1684 US$5686–16,568/LYS 0.108 (0.054–0.162) 746–2175
BC36,49 7 to save a life 584–1139 US$21,400/LYS 0.009 (0.006–0.012) 236
CC37,38,50 6 to save a life 1140–2560 US$4050/LYS 0.003 (0.002–0.005) 19
OS39,51 3 to prevent a vertebral 75–248 US$27,000/LYS 0.026 (0.012–0.040) 855
fracture
Overall 0.822 (0.475–1.169) 21,996–32,587
program
No. = number of cases actually taking up preventive services; LYS = life-year saved; QALY = quality-adjusted life-year; N/A = not available.
(1 pound = 1.80 US$, 1 Euro = 1.23 US$).
on the questionnaire was clear enough; however,
many of them did not regard preventive inter-
ventions as such an urgent necessity that they
should visit a clinic or they just did not bother to
answer. A preliminary analysis of the question-
naires from phone interviewees showed that the
prevalence of existing diseases (diabetes, hyper-
tension, dyslipidemia) was similar to those who
responded by mail. All of the phone interviewees
also needed one to six preventive interventions.
The subjects who responded to the question-
naires were likely to be more educated, more con-
cerned about health, and have easier access to
medical care. Although interpretation of the data
of this highly selected group should be cautious,
the survey might still provide information about
local epidemiology. The prevalence of diabetes
was 13.4% for men and 5.8% for women in this
study; previous studies showed that the prevalence
of type 2 diabetes in Taiwanese aged ≥40 years was
11–13%.52 According to the survey of the Bureau
of Health Promotion of Taiwan, the prevalence of
hypertension was 26% in male and 19% in female
adults, which are also compatible with our esti-
mates (28.3% and 19.7%).53
On the other hand, the attendance rate for de-
pression and osteoporosis was low, but the yield
rate was both 100%. This finding suggested that
the protocol might have expelled patients who
were at risk. Only a few depressive patients could
be expected to complete the depression evalua-
tion and return to a psychiatric clinic. In Taiwan,
the expense of the bone mineral densitometry test
is not fully covered by the Bureau of National
Health Insurance, and is therefore a substantial
burden to the elderly women of Yun-Lin. Both the
response rate and attendance rate indicate new 
directions for the development of screening strate-
gies, selection of target populations, and making
health policies.
Another major concern is the lower attendance
in women compared to men. The effectiveness of
screening for breast cancer, cervical cancer, and
osteoporosis in women at risk was not substantial
in our program. The attendance rate of women who
ultimately received Pap smear, mammography,
and bone mineral densitometry was low (10.0–
17.6%) (Table 4). The attitude of women toward
examinations of private body parts remains a social
stigma in the rural areas of Taiwan. The cultural
impact on the health-seeking behavior of women
should be explored so as to design a better proto-
col to improve women’s health.
Conclusion
A multiple screening program driven by USPSTF
recommendations and aided by a computerized
decision support system has been successfully
implemented in Yun-Lin, Taiwan. The protocol
capable of offering patient education and auto-
matic recommendations could be life-saving and
cost-effective. The screening results have also
provided information about local epidemiology
and implications for future health policy mak-
ing. Future efforts will be needed to improve the
response rate and the attendance rate to preven-
tive services and to expand the protocol into a
mass screening program.
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